Skip to main content
Search Button
United States Kobo store Gift Cards Help

Rakuten Kobo

Wishlist

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...


Top Series in United States

Showing 1 - 12 of 12 results for “daniel b costa”
Skip side bar filters

  • EGFR-Directed Therapy in Lung Cancer

    by So Yeon Kim, Daniel B. Costa, Daisuke Shibahara, Susumu Kobayashi, Balazs Halmos ...
    Series series Elements in Molecular Oncology
    Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) is a clinically important driver alteration affecting approximately one-third of lung cancer patients. Treatments for EGFR-exon 19 deletion and exon 21 L858R NSCLC have evolved over the last decade from first-generation reversible tyrosine kinase inhibitors (TKI) to third-generation irreversible TKIs, of which ... Read more

    $20.49 USD

People who read this also enjoyed

  • Variant Haemoglobins

    A Guide to Identification

    by Barbara J. Bain, Barbara Wild, Adrian Stephens, Lorraine Phelan ...
    Variant Haemoglobins – A Guide to Identification is based on the premise that any single diagnostic technique offers only a very provisional identification of a variant haemoglobin. In routine diagnostic practice two techniques are needed as a minimum, with the results being interpreted in the light of the clinical details, blood count, blood film and ethnic origin. This book covers 150 normal and ... Read more

    $176.75 USD

  • Lymphomas

    by John W. Sweetenham, MD, Jame Abraham, MD, FACP ...
    Series series Emerging Cancer Therapeutics
    Emerging Cancer Therapeutics is a trinary hard cover periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, ... Read more

    $93.59 USD

  • Fast Facts: Chronic Lymphocytic Leukemia

    by T.A. Eyre, P. Jasani, L.E. Roeker ...
    Chronic lymphocytic leukemia (CLL) is the most diagnosed leukemia in the Western world, accounting for approximately 25% of all new leukemia diagnoses. In recent years, remarkable progress has been made in our understanding of both the pathophysiology and genetics of CLL. While the disease generally affects older adults and initially follows an indolent course, cytogenetic and molecular profiling ... Read more

    Free

  • Targeting Protein Kinases for Cancer Therapy

    by David J. Matthews, Mary E. Gerritsen ...
    An expert guide to targeting protein kinases in cancer therapyResearch has shown that protein kinases can instigate the formation and spread of cancer when they transmit faulty signals inside cells. Because of this fact, pharmaceutical scientists have targeted kinases for intensive study, and have been working to develop medicinal roadblocks to sever their malignant means of communication.Complete ... Read more

    $148.00 USD

  • Metronomic Chemotherapy

    Pharmacology and Clinical Applications

    Edited by Guido Bocci, Giulio Francia ...
    Series series Biomedical and Life Sciences (R0)
    This book analyzes all aspects of metronomic chemotherapy, a new approach involving low-dose, long-term, and frequently administered therapy that has preclinical and clinical activity in various tumors. After an opening section on the pharmacological bases of metronomic chemotherapy, including its antiangiogenic effects and impact on immunity, preclinical studies on various classes of drug are ... Read more

    $89.09 USD

  • Novel Developments in Stem Cell Mobilization

    Focus on CXCR4

    Edited by Stefan Fruehauf, Gary Calandra, W. Jens Zeller ...
    Series series Biomedical and Life Sciences (R0)
    Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell ... Read more

    $143.09 USD

  • Hodgkin's Lymphoma, An Issue of Hematology/Oncology

    Hodgkin's Lymphoma, An Issue of Hematology/Oncology

    by Volker Diehl, MD ...
    Series Book Volume 28-1 - The Clinics: Internal Medicine
    This issue of Hematology/Oncology Clinics is focused on Hodgkin's Lymphoma and covers such topics as First HRS-cell line L428 and the detection of the CD-30 Antigen , “Normal“ CD30-B-lymphocytes, CD-30-Antigen, Combination-Chemo-Radiotherapy, Early intensification (escBEACOPP), Customized/Targeted Therapy, and more. ... Read more

    $75.59 USD

  • Combining Targeted Biological Agents with Radiotherapy

    Current Status and Future Directions

    by William Small Jr., MD ...
    Radiotherapy plays an integral role in cancer treatment. Approximately 60% of cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agents with radiotherapy is the latest cutting-edge extension in cancer therapy for radiation ... Read more

    $161.99 USD

  • New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America

    by Franco Muggia ...
    Series Book Volume 26-3 - The Clinics: Internal Medicine
    Topics include: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors , and New Strategies and Drugs Inhibiting Folate Pathways. ... Read more

    $75.59 USD

  • The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America

    by Ann Mullally, MD ...
    Series Book Volume 31-4 - The Clinics: Internal Medicine
    This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next ... Read more

    $83.69 USD

  • Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

    Edited by Jianguo Tao, Eduardo Sotomayor ...
    Series series Medicine (R0)
    In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack ... Read more

    $143.09 USD